$BDTX
Black Diamond Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$2.11
▲+16.57%+$0.300
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBlack Diamond Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is BDTX up today? It is at $2.11 (+16.57%), and our scanner flagged it 44 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BDTX spikes, and full due diligence on BDTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BDTX 44 times in the last 30 days. Create a free account to track $BDTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BDTX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Latest filing4Insider trade (Form 4)Sep 21, 2026 · 29 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Raman Prakash Director | Acquired (grant/award) | +7K 0.01% of company | added 15% | 52K | $13K at $1.93 | Sep 18, 26 |
Behbahani Ali Director | Acquired (grant/award) | +8K 0.01% of company | added 7.5% | 110K | $15K at $1.93 | Sep 18, 26 |
Raman Prakash Director | Acquired (grant/award) | +8K 0.01% of company | added 21% | 45K | $13K at $1.66 | Jun 19, 26 |
Behbahani Ali Director | Acquired (grant/award) | +9K 0.02% of company | added 9.6% | 103K | $15K at $1.66 | Jun 19, 26 |
Raman Prakash Director | Acquired (grant/award) | +6K 0.01% of company | added 20% | 37K | $13K at $2.15 | Mar 20, 26 |
Behbahani Ali Director | Acquired (grant/award) | +7K 0.01% of company | added 8.0% | 94K | $15K at $2.15 | Mar 20, 26 |
Raman Prakash Director | Acquired (grant/award) | +5K | added 18% | 31K | $13K at $2.76 | Dec 12, 25 |
Behbahani Ali Director | Acquired (grant/award) | +5K | added 6.4% | 87K | $14K at $2.76 | Dec 12, 25 |
Raman Prakash Director | Acquired (grant/award) | +4K | added 17% | 26K | $13K at $3.35 | Sep 19, 25 |
Behbahani Ali Director | Acquired (grant/award) | +4K | added 5.6% | 81K | $14K at $3.35 | Sep 19, 25 |
Raman Prakash Director | Acquired (grant/award) | +6K | added 33% | 23K | $13K at $2.33 | Jun 20, 25 |
Behbahani Ali Director | Acquired (grant/award) | +6K 0.01% of company | added 8.7% | 77K | $14K at $2.33 | Jun 20, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on BDTX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
BDTX last traded at $2.11, up 16.57% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Black Diamond Therapeutics, Inc. Common Stock (BDTX) is next expected to report earnings on Thursday, November 5, 2026, about 16 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BDTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BDTX 44 times in the last 30 days.
BDTX (Black Diamond Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $104M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BDTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BDTX discussion
Sign in to ask a question or join the discussion.